Search Results

< Prev
1 of 2
Next >

News Releases

May 16, 2013, 09:09 ET

Strategic move to strengthen Consumer Care business: Bayer to acquire Steigerwald Arzneimittelwerk GmbH

Bayer signed an agreement Thursday to acquire 100% of the shares of Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany, a privately held pharmaceutical company specializing in pharmacy-only herbal medicines. Steigerwald's product portfolio includes Iberogast® for the treatment of functional...

More news about: Bayer HealthCare , Steigerwald Arzneimittelwerk GmbH
May 15, 2013, 18:01 ET

Bayer to Present New Data Across Oncology Portfolio at ASCO 2013

Intended for U.S. Media Only -- Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar® (sorafenib) tablets, Stivarga® (regorafenib) tablets and the recently U.S. Food and Drug Administration (FDA) approved product Xofigo® (radium Ra...

More news about: Bayer HealthCare Pharmaceuticals Inc. , American Society of Clinical Oncology (ASCO)
May 15, 2013, 11:40 ET

Bayer Receives U.S. FDA Approval for Xofigo® (radium Ra 223 dichloride) Injection as a New Treatment for Castration-Resistant Prostate Cancer with Bone Metastases

Intended for U.S. Media Only -- Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) approved Xofigo® (radium Ra 223 dichloride) for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic bone metastases and no known visceral...

More news about: Bayer HealthCare Pharmaceuticals Inc.
May 15, 2013, 02:30 ET

Bayer Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Advanced Liver Cancer

Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga® (regorafenib) tablets for the treatment of patients with...

More news about: Bayer HealthCare Pharmaceuticals Inc. , Bayer HealthCare LLC , Bayer AG
May 10, 2013, 13:05 ET

Bayer HealthCare Committed to Growing Animal Health Business

Bayer HealthCare LLC Animal Health division expanded their product portfolio and introduced seven products to the market as the company continues the integration process following the recent acquisition of Teva Animal Health Inc. based in St. Joseph, MO. Seven DVM® dermatology products...

More news about: Bayer HealthCare LLC , Teva Animal Health Inc.
May 10, 2013, 13:01 ET

Bayer Employee Named Rising Star by Healthcare Businesswomen's Association

Bayer HealthCare is pleased to announce that Carla Oliveira has been named a Rising Star by The Healthcare Businesswomen's Association (HBA). She was honored at the annual HBA Woman of the Year luncheon in New York City on May 9. Carla is the Global Brand Leader for...

More news about: Bayer HealthCare , Healthcare Businesswomen's Association
May 08, 2013, 08:00 ET

Bayer to Present Data on Investigational Pulmonary Hypertension Compound Riociguat at ATS 2013

Bayer HealthCare announced today that data on its investigational pulmonary hypertension compound riociguat (BAY 63-2521) will be presented in a scientific forum at the American Thoracic Society (ATS) International Conference May 17 – 22, in Philadelphia, PA. "We are pleased that...

More news about: Bayer HealthCare Pharmaceuticals Inc.
May 07, 2013, 17:30 ET

Don't Leave Home Without It: Vanessa Williams, Bayer HealthCare and WomenHeart Launch Handbags & Hearts to Urge Women to Make Over Their Handbags to Include Aspirin and Be Better Prepared for a Heart Attack

Bayer HealthCare, the makers of Bayer® Aspirin, WomenHeart: The National Coalition for Women with Heart Disease, and actress, singer and author Vanessa Williams today announce their partnership to launch Handbags & Hearts, a national campaign that leverages the link between women and...

More news about: Bayer HealthCare , Women Heart
May 07, 2013, 17:22 ET

Bayer commences cash tender offer for all outstanding shares of Conceptus, Inc.

Bayer's planned acquisition of Conceptus, Inc., based in Mountain View, California (NASDAQ: CPTS) is entering its next phase: Evelyn Acquisition Company, a subsidiary established by Bayer HealthCare LLC, Tarrytown, N.Y., for the purpose of the acquisition, is commencing today a cash tender...

More news about: Bayer HealthCare , Conceptus, Inc. , Evelyn Acquisition Company
May 07, 2013, 09:00 ET

Colorado State University Student Wins Bayer Excellence in Communication Award National Scholarship

Bayer HealthCare LLC, Animal Health Division is proud to announce that Jessica Bridge, a junior at Colorado State University's College of Veterinary Medicine & Biomedical Sciences, is the inaugural national winner of the Bayer Excellence in Communication Award. Bayer HealthCare Animal...

More news about: Bayer HealthCare LLC
May 02, 2013, 09:00 ET

Bayer HealthCare Introduces Seresto™, Offering Easy-To-Use Flea and Tick Control for Dogs or Cats that Lasts Eight Months

Bayer HealthCare LLC Animal Health Division has now provided dog and cat owners the same performance they expect from a monthly flea and tick topical in an easy-to-use, convenient collar that protects for eight months. Seresto™, manufactured by Bayer, is an effective flea and tick...

More news about: Bayer HealthCare LLC
May 01, 2013, 13:43 ET

Putting Meals on the Table for People in Need: Sheryl Crow and One A Day® Women's Brand on a Nutrition Mission to Help Feed the More Than 50 Million Americans Facing Food Insecurity

Today, Bayer HealthCare LLC, the makers of One A Day® Women's Multivitamins, along with Feeding America®, the nation's leading domestic hunger-relief charity, and nine-time Grammy Award winner Sheryl Crow kick off year two of their Nutrition Mission with the announcement of a...

More news about: Bayer Healthcare
Apr 30, 2013, 11:09 ET

Ryan & Maniskas, LLP Announces Investigation of Conceptus, Inc.

Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/cpts) is investigating potential claims against the board of directors of Conceptus, Inc. ("Conceptus" or the "Company") (NASDAQ: CPTS) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to...

More news about: Ryan & Maniskas, LLP , Conceptus, Inc. , Bayer HealthCare LLC
Apr 29, 2013, 17:53 ET

Acquisition of Conceptus, Inc. by Bayer HealthCare LLC May Not Be in the Best Interests of Conceptus Shareholders

Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Conceptus, Inc. (NASDAQ: CPTS) by Bayer HealthCare LLC. On April 29, 2013, Bayer announced the signing of a merger agreement with Conceptus whereby Bayer will launch a public tender offer to acquire...

More news about: Robbins Arroyo LLP , Conceptus, Inc. , Bayer HealthCare LLC
Apr 29, 2013, 16:52 ET

Harwood Feffer LLP Announces Investigation of Conceptus, Inc.

Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Conceptus, Inc. ("Conceptus" or the "Company") (NASDAQ: CPTS) concerning the proposed acquisition of the Company by Bayer Healthcare LLC ("Bayer") in a transaction valued at approximately...

More news about: Harwood Feffer LLP , Conceptus, Inc. , Bayer Healthcare LLC
Apr 29, 2013, 10:39 ET

Conceptus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bayer HealthCare LLC

Bernstein Liebhard LLP is investigating whether the Board of Directors of Conceptus, Inc. ("Conceptus" or the "Company") (NASDAQ: CPTS) breached its fiduciary duty to its shareholders in agreeing to sell Conceptus to Bayer HealthCare LLC. (Logo:...

More news about: Bernstein Liebhard LLP , Bayer HealthCare LLC , Conceptus, Inc.
Apr 29, 2013, 02:30 ET

Bayer to acquire Conceptus, Inc.

Bayer intends to broaden its portfolio in the field of contraception. Thus, Bayer HealthCare LLC has signed a merger agreement with Conceptus, Inc. (NASDAQ:CPTS), the California-based developer of the Essure® procedure, the leading non-surgical permanent birth control method, which is...

More news about: Bayer HealthCare Pharmaceuticals Inc. , Conceptus, Inc.
Apr 16, 2013, 16:15 ET

Actavis Confirms Favorable Ruling in Generic Yaz® Patent Suit

Actavis, Inc. (NYSE: ACT) today announced that it has re-launched Vestura™ (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer HealthCare Pharmaceuticals Inc.'s Yaz® oral contraceptive product, following a ruling from the United States Court of Appeals for...

More news about: Actavis, Inc. , Bayer HealthCare Pharmaceuticals Inc.
Apr 16, 2013, 05:00 ET

Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia

Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated...

More news about: Bayer HealthCare Pharmaceuticals Inc. , Nektar Therapeutics